Invesco Ltd. Exagen Inc. Put Options Transaction History
Invesco Ltd.
- $600 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding XGN
# of Institutions
58Shares Held
9.71MCall Options Held
0Put Options Held
0-
Rtw Investments, LP New York, NY1.7MShares$15.7 Million0.18% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6851KShares$7.87 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA734KShares$6.79 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL719KShares$6.65 Million0.01% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO552KShares$5.1 Million0.15% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $150M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...